Acute and long-term NCX activation reduces brain injury and restores behavioral functions in mice subjected to neonatal brain ischemia

Neuropharmacology. 2018 Jun:135:180-191. doi: 10.1016/j.neuropharm.2018.03.017. Epub 2018 Mar 15.

Abstract

Hypoxic-ischemic encephalopathy (HI) accounts for the majority of developmental, motor and cognitive deficits in children, leading to life-long neurological impairments. Since the plasmamembrane sodium/calcium exchanger (NCX) plays a fundamental role in maintaining ionic homeostasis during adult brain ischemia, in the present work we aimed to demonstrate (1)the involvement of NCX in the pathophysiology of neonatal HI and (2)a possible NCX-based pharmacological intervention. HI was induced in neonatal mice at postnatal day 7(P7) by unilateral cut of the right common carotid artery, followed by 60 min exposure to 8%O2. Expression profiles of NCX isoforms from embryos stage to adulthood was evaluated in the hippocampus of hypoxic-ischemic and control mice. To assess the effect of NCX pharmacological stimulation, brain infarct volume was evaluated in brain sections, obtained at several time intervals after systemic administration of the newly synthesized NCX activator neurounina. Moreover, the long term effect of NCX activation was evaluated in adult mice (P60) subjected to neonatal HI and daily treated with neurounina for three weeks. Hypoxic-ischemic insult induced a reduction of NCX1 and NCX3 expression starting from day 7 until day 60. Notably, 8 weeks after HI induction in P7 mice, NCX pharmacological stimulation not only reduced infarct volume but improved also motor behaviour, spatial and visual memory. The present study highlights the significant role of NCX in the evolution of neonatal brain injury and in the learning and memory processes that are impaired in mice injured in the neonatal period.

Keywords: Learning and memory; Motor behaviour; Na+/Ca2+ exchanger; Neonatal hypoxia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Behavior, Animal / drug effects
  • Benzodiazepinones / pharmacology*
  • Benzodiazepinones / therapeutic use
  • Brain / pathology
  • Female
  • Hippocampus / metabolism
  • Hypoxia-Ischemia, Brain / drug therapy*
  • Hypoxia-Ischemia, Brain / metabolism
  • Hypoxia-Ischemia, Brain / pathology
  • Hypoxia-Ischemia, Brain / prevention & control*
  • Male
  • Mice
  • Protein Isoforms
  • Pyrrolidines / pharmacology*
  • Pyrrolidines / therapeutic use
  • Sodium-Calcium Exchanger / biosynthesis
  • Sodium-Calcium Exchanger / metabolism*
  • Time Factors

Substances

  • 7-nitro-5-phenyl-1-(pyrrolidin-1-ylmethyl)-1H-benzo(e)(1,4)diazepin-2(3H)-one
  • Benzodiazepinones
  • NCX1 protein, mouse
  • Protein Isoforms
  • Pyrrolidines
  • Slc8a3 protein, mouse
  • Sodium-Calcium Exchanger